55414-45-4 Usage
Description
(2-amino-3-bromo-5-fluorophenyl)methanol is a phenol derivative with the molecular formula C7H7BrFNO. It features an amino group, a bromine atom, and a fluorine atom attached to a phenyl ring, making it a versatile building block in organic synthesis and medicinal chemistry.
Uses
Used in Pharmaceutical Industry:
(2-amino-3-bromo-5-fluorophenyl)methanol is used as a building block for the synthesis of pharmaceuticals due to its unique functional groups and structural features, which can be utilized in the development of new drugs.
Used in Agrochemical Industry:
(2-amino-3-bromo-5-fluorophenyl)methanol is used as a precursor in the production of agrochemicals, contributing to the development of innovative and effective crop protection agents.
Used in Organic Synthesis:
(2-amino-3-bromo-5-fluorophenyl)methanol is used as a chemical intermediate in the synthesis of various functionalized aromatic compounds, expanding the scope of organic chemistry.
Used in Biochemical Production:
(2-amino-3-bromo-5-fluorophenyl)methanol may have applications as a chemical intermediate in the production of organic and biochemical products, further highlighting its utility in the field of chemistry and drug discovery.
Check Digit Verification of cas no
The CAS Registry Mumber 55414-45-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,5,4,1 and 4 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 55414-45:
(7*5)+(6*5)+(5*4)+(4*1)+(3*4)+(2*4)+(1*5)=114
114 % 10 = 4
So 55414-45-4 is a valid CAS Registry Number.
55414-45-4Relevant articles and documents
CONDENSED-RING PYRIMIDYLAMINO DERIVATIVE, PREPARATION METHOD THEREFOR, AND INTERMEDIATE, PHARMACEUTICAL COMPOSITION AND APPLICATIONS THEREOF
-
, (2018/03/25)
Disclosed are a condensed-ring pyrimidylamino derivative, a preparation method therefor, and an intermediate, a pharmaceutical composition and applications thereof. The method for preparing the condensed-ring pyrimidylamino derivative comprises: in a solvent, in the presence of a palladium-containing catalyst, allowing a compound represented by formula I-a and a compound represented by formula I-b' to have a coupling reaction, and then preparing a compound represented by formula I by means of a deprotection reaction. Also disclosed applications of the condensed-ring pyrimidylamino derivative in the preparation of drugs for preventing, relieving and/or treating tumors or diseases caused by an anaplastic lymphoma kinase. The condensed-ring pyrimidylamino derivative of the present invention has an obvious restraint effect on the anaplastic lymphoma kinase.
QUINAZOLINES FOR PDK1 INHIBITION
-
Page/Page column 331, (2008/06/13)
The invention provides novel quinazoline compounds that are inhibitors of PDK1. Also provided are pharmaceutical compositions including the compounds, and methods of treating proliferative diseases, such as cancers, with the compounds or compositions.
